Glipizide ER 5mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, take it exactly as directed by your doctor. Carefully read all the information provided with your prescription and follow the instructions closely.
Take your medication with the first meal of the day.
Swallow the tablet whole - do not chew, break, crush, or dissolve it.
If you have a change in your eating habits or skip a meal, be aware of how this may affect your medication and know what steps to take.
Storing and Disposing of Your Medication
To maintain the quality and safety of your medication:
Store it at room temperature in a dry place, avoiding the bathroom.
Keep it in its original container.
Store all medications in a secure location, out of the reach of children and pets.
What to Do If You Miss a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses.
Lifestyle & Tips
- Take Glipizide ER once daily with breakfast to ensure consistent blood sugar control and reduce the risk of low blood sugar.
- Follow a healthy diet plan recommended by your doctor or dietitian.
- Engage in regular physical activity as advised by your healthcare provider.
- Monitor your blood sugar levels regularly as instructed by your doctor.
- Carry a source of fast-acting sugar (e.g., glucose tablets, hard candy, fruit juice) to treat low blood sugar if it occurs.
- Limit or avoid alcohol consumption, as it can increase the risk of low blood sugar and other side effects.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Changes in eyesight
Slurred speech
Tingling
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling very tired or weak
Additionally, low blood sugar (hypoglycemia) can occur, especially when this medication is used with other diabetes medications. If you experience any of the following symptoms, contact your doctor right away:
Dizziness
Headache
Feeling sleepy or weak
Shaking
Fast heartbeat
Confusion
Hunger
Sweating
Follow your doctor's instructions for managing low blood sugar, which may include taking glucose tablets, liquid glucose, or some fruit juices.
Other Possible Side Effects
Most people do not experience significant side effects, but some may occur. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention if they bother you or do not go away:
Dizziness
Diarrhea
Feeling nervous and excitable
* Gas
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Symptoms of low blood sugar (hypoglycemia): sweating, shaking, dizziness, confusion, hunger, irritability, headache, blurred vision, rapid heartbeat. If these occur, treat immediately with a fast-acting sugar source.
- Symptoms of high blood sugar (hyperglycemia): increased thirst, increased urination, fatigue, blurred vision (less common with sulfonylureas alone, but important to recognize if blood sugar is not controlled).
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced.
A known sulfa allergy.
Any narrowing of the gastrointestinal (GI) tract or a bowel blockage.
Acidic blood conditions, such as those that affect your blood's pH balance.
* If you have type 1 diabetes, as this medication is not intended to treat this condition.
This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins, with your doctor and pharmacist. They will help determine if it is safe to take this medication with your existing treatments and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Regular blood work is crucial, so follow your doctor's recommendations for check-ups and discuss any concerns with them. Be aware that this medication may interfere with certain lab tests, so notify all healthcare providers and lab personnel that you are taking this drug.
Adhere to the diet and exercise plan recommended by your doctor. If you experience low blood sugar, avoid driving, as it increases the risk of accidents. Additionally, refrain from consuming alcohol while taking this medication. If you are also taking colesevelam, take it at least 4 hours after taking this drug.
Be mindful that stress, such as fever, infection, injury, or surgery, can affect blood sugar control. Changes in physical activity, exercise, or diet may also impact blood sugar levels. If you have low levels of the enzyme G6PD, exercise caution, as you may be more prone to anemia. This condition is more common in individuals of African, South Asian, Middle Eastern, and Mediterranean descent.
This medication may increase the risk of heart disease-related death, so discuss this with your doctor. Be aware that low blood sugar can occur, and severe cases can lead to seizures, loss of consciousness, long-term brain damage, and even death. Consult your doctor if you experience any concerns.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, as you will need to discuss the benefits and risks to you and your baby.
You may notice the tablet shell in your stool, but this is a normal occurrence and not a cause for concern. However, if you take this medication during pregnancy, you may need to stop taking it before your due date, as low blood sugar has been reported in infants born to mothers who took similar medications. Consult your doctor to determine the best course of action.
Overdose Information
Overdose Symptoms:
- Severe hypoglycemia (extremely low blood sugar)
- Confusion
- Disorientation
- Slurred speech
- Seizures
- Loss of consciousness
- Coma
What to Do:
Immediately consume a fast-acting source of sugar (e.g., glucose tablets, fruit juice, regular soda). If the person is unconscious or unable to swallow, call 911 or emergency medical services immediately. Glucagon injection may be necessary. After recovery, monitor blood glucose closely for at least 24-48 hours due to the prolonged effect of the extended-release formulation and potential for recurrent hypoglycemia. Call 1-800-222-1222 (Poison Control).
Drug Interactions
Major Interactions
- Bosentan (increased risk of hepatotoxicity)
- Miconazole (oral, IV, topical) - significantly enhances hypoglycemic effect
- Alcohol (acute ingestion - disulfiram-like reaction, chronic ingestion - enhanced hypoglycemia)
Moderate Interactions
- Beta-blockers (mask symptoms of hypoglycemia, impair glucose counter-regulation)
- NSAIDs (e.g., ibuprofen, naproxen - enhance hypoglycemic effect)
- Salicylates (e.g., aspirin - enhance hypoglycemic effect at high doses)
- Sulfonamides (e.g., sulfamethoxazole/trimethoprim - enhance hypoglycemic effect)
- Chloramphenicol (enhance hypoglycemic effect)
- Coumarin derivatives (e.g., warfarin - enhance hypoglycemic effect)
- Probenecid (enhance hypoglycemic effect)
- MAO inhibitors (enhance hypoglycemic effect)
- Fluconazole, Ketoconazole (inhibit CYP2C9, increasing glipizide levels)
- Cimetidine (increases glipizide levels)
- Thiazide diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, isoniazid (may cause hyperglycemia, requiring dose adjustment of glipizide)
- Rifampin (induces CYP2C9, decreasing glipizide levels)
Minor Interactions
- Chromium supplements (may enhance glucose lowering)
Monitoring
Baseline Monitoring
Rationale: To establish baseline glycemic control and guide initial dosing.
Timing: Prior to initiation of therapy
Rationale: To establish baseline glycemic control and guide initial dosing.
Timing: Prior to initiation of therapy
Rationale: To assess kidney function, as glipizide is primarily renally eliminated and renal impairment increases risk of hypoglycemia.
Timing: Prior to initiation of therapy
Rationale: To assess liver function, as glipizide is metabolized in the liver and hepatic impairment increases risk of hypoglycemia.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Every 3-6 months
Target: <7% (individualized)
Action Threshold: >7% (consider dose adjustment or additional therapy)
Frequency: Daily or several times per week (self-monitoring)
Target: 80-130 mg/dL (individualized)
Action Threshold: <70 mg/dL (hypoglycemia, requires intervention); >180 mg/dL (hyperglycemia, consider dose adjustment)
Frequency: Daily (patient self-monitoring)
Target: N/A
Action Threshold: Any occurrence of symptoms (e.g., sweating, tremor, confusion, hunger, dizziness) requires immediate action (consume fast-acting carbohydrate) and re-evaluation of therapy.
Frequency: Annually or more frequently if clinically indicated (e.g., in elderly or those with comorbidities)
Target: Stable eGFR
Action Threshold: Significant decline in eGFR (consider dose reduction or discontinuation)
Frequency: Annually or more frequently if clinically indicated
Target: Normal liver enzymes
Action Threshold: Significant elevation in liver enzymes (consider discontinuation)
Symptom Monitoring
- Symptoms of hypoglycemia: sweating, tremor, dizziness, confusion, hunger, irritability, headache, blurred vision, rapid heartbeat, anxiety, weakness, slurred speech, seizures, coma.
- Symptoms of hyperglycemia (less common with sulfonylureas alone): increased thirst, increased urination, fatigue, blurred vision.
Special Patient Groups
Pregnancy
Glipizide is Pregnancy Category C. It is generally not recommended for use during pregnancy. Insulin is the preferred treatment for diabetes during pregnancy due to better glycemic control and lower risk of fetal adverse effects.
Trimester-Specific Risks:
Lactation
Glipizide is excreted into breast milk. Due to the potential for hypoglycemia in the breastfed infant, Glipizide is generally not recommended during breastfeeding. Insulin is the preferred treatment for diabetes in lactating women.
Pediatric Use
Safety and effectiveness in pediatric patients have not been established. Use is not recommended.
Geriatric Use
Elderly patients are more susceptible to the hypoglycemic effects of sulfonylureas due to age-related decline in renal function, hepatic function, and glucose counter-regulation. Start with a lower dose (e.g., 2.5 mg) and titrate cautiously. Monitor blood glucose closely and educate patients and caregivers on hypoglycemia symptoms and management. Avoid in frail elderly or those with multiple comorbidities.
Clinical Information
Clinical Pearls
- Always take Glipizide ER with breakfast to minimize the risk of hypoglycemia and ensure consistent drug absorption.
- Glipizide ER is designed for once-daily dosing; do not crush, chew, or divide the tablets, as this will destroy the extended-release properties and can lead to rapid absorption and hypoglycemia.
- Patients should be educated on the symptoms of hypoglycemia and how to treat it immediately.
- Be cautious when prescribing to patients with renal or hepatic impairment, as the risk of prolonged hypoglycemia is significantly increased.
- Consider the patient's lifestyle and adherence capabilities; sulfonylureas require consistent meal patterns.
- The 'ghost tablet' (empty shell) may be seen in the stool, which is normal and does not mean the medication was not absorbed.
Alternative Therapies
- Metformin (first-line for most Type 2 DM patients)
- DPP-4 inhibitors (e.g., sitagliptin, saxagliptin)
- SGLT2 inhibitors (e.g., empagliflozin, canagliflozin)
- GLP-1 receptor agonists (e.g., liraglutide, semaglutide)
- Thiazolidinediones (e.g., pioglitazone)
- Meglitinides (e.g., repaglinide, nateglinide - shorter acting insulin secretagogues)
- Insulin therapy